New York, NY – May 26, 2015 – Health Enterprise Partners (“HEP”), a health care focused growth equity firm, is pleased to announce that Pete Tedesco has joined the firm as a Vice President. Pete will focus on buyout and growth equity transactions in health care services and information technology.
“Pete is a highly accomplished investor with a proven track record in terms of working with portfolio companies to deliver above market returns,” said David Tamburri, General Partner at HEP. “He will contribute buyout experience and deep knowledge to the team as we continue to build our firm.”
Prior to joining HEP, Pete was as a Vice President at Olympus Partners, a middle-market private equity firm based in Stamford, CT. At Olympus, he was responsible for evaluating and executing leveraged buyout and growth equity transactions and served on the board of directors for companies across a variety of industries. Pete previously worked at Chicago- based private equity firm Waud Capital Partners, where he focused primarily on investments in the healthcare services sector, and in the Corporate Business Development group at medical technology company Becton Dickinson & Co. (NYSE: BDX). Pete began his career in the Mergers & Acquisitions and Diversified Industrials groups at UBS Investment Bank.
Pete holds an A.B. from Princeton University and an M.B.A. from the Kellogg School of Management at Northwestern University.
“HEP’s deep health care industry knowledge and strategic investor base are true differentiators in today’s crowded investment world,” said Mr. Tedesco. “I am thrilled to join the HEP team and look forward to building upon the firm’s outstanding performance.”
About Health Enterprise Partners
Health Enterprise Partners invests primarily in privately held, profitable, middle market companies in the health care information technology and health care service sectors. HEP’s strategy is to leverage its unique and extensive hospital system and health plan network, 25 members of which are investors in HEP’s funds. HEP seeks to invest in companies that improve the quality of the patient experience, reduce the cost of health care, and improve operating margins for their customers, typically hospital systems and / or health plans.